Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma
Clinical trial NCT04477486 · COMPLETED
Trial details
- NCT number
- NCT04477486
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2022-02-09
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.